Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer
Christian A. Kuttruff(Boehringer Ingelheim (Germany)), Thorsten Oost(Abbott (United States)), Martin Fleck(Asklepios Kliniken Bad Abbach), Achim Grube(Boehringer Ingelheim (Germany)), Georg Rast(WWF Germany), Maria Antonietta Impagnatiello(Boehringer Ingelheim (Austria)), Heribert Arnhof(Boehringer Ingelheim (Austria)), Marco H. Hofmann(Boehringer Ingelheim (Austria)), Herbert Nar(Boehringer Ingelheim (Germany)), Sandra Handschuh(Boehringer Ingelheim (Germany)), Otmar Schaaf(Boehringer Ingelheim (Austria)), Sebastian Carotta(Boehringer Ingelheim (Austria)), Georg Dahmann(Boehringer Ingelheim (Germany)), Gabriela Gremel(Boehringer Ingelheim (Austria)), Annekatrin Heimann(Boehringer Ingelheim (Germany)), Esther Schmidt(European Bioinformatics Institute), Tom Bretschneider(Boehringer Ingelheim (Germany))
Cited by 15
Related Papers
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383